Back to Search Start Over

Atomoxetine modulates the relationship between perceptual abilities and response bias.

Authors :
Guedj C
Reynaud A
Monfardini E
Salemme R
Farnè A
Meunier M
Hadj-Bouziane F
Source :
Psychopharmacology [Psychopharmacology (Berl)] 2019 Dec; Vol. 236 (12), pp. 3641-3653. Date of Electronic Publication: 2019 Aug 05.
Publication Year :
2019

Abstract

Elucidation of how neuromodulators influence motivated behaviors is a major challenge of neuroscience research. It has been proposed that the locus-cœruleus-norepinephrine system promotes behavioral flexibility and provides resources required to face challenges in a wide range of cognitive processes. Both theoretical models and computational models suggest that the locus-cœruleus-norepinephrine system tunes neural gain in brain circuits to optimize behavior. However, to the best of our knowledge, empirical proof demonstrating the role of norepinephrine in performance optimization is scarce. Here, we modulated norepinephrine transmission in monkeys performing a Go/No-Go discrimination task using atomoxetine, a norepinephrine-reuptake inhibitor. We tested the optimization hypothesis by assessing perceptual sensitivity, response bias, and their functional relationship within the framework of the signal detection theory. We also manipulated the contingencies of the task (level of stimulus discriminability, target stimulus frequency, and decision outcome values) to modulate the relationship between sensitivity and response bias. We found that atomoxetine increased the subject's perceptual sensitivity to discriminate target stimuli regardless of the task contingency. Atomoxetine also improved the functional relationship between sensitivity and response bias, leading to a closer fit with the optimal strategy in different contexts. In addition, atomoxetine tended to reduce reaction time variability. Taken together, these findings support a role of norepinephrine transmission in optimizing response strategy.

Details

Language :
English
ISSN :
1432-2072
Volume :
236
Issue :
12
Database :
MEDLINE
Journal :
Psychopharmacology
Publication Type :
Academic Journal
Accession number :
31384989
Full Text :
https://doi.org/10.1007/s00213-019-05336-7